| Literature DB >> 11850279 |
John Scovill1, Elizabeth Blank, Michael Konnick, Elizabeth Nenortas, Theresa Shapiro.
Abstract
New drugs and molecular targets are needed against Trypanosoma brucei, the protozoan that causes African sleeping sickness. Tryptanthrin (indolo[2,1-b]quinazoline-6,12-dione), a traditional antifungal agent, and 11 analogs were tested against T. brucei in vitro. The greatest activity was conferred by electron-withdrawing groups in the 8 position of the tryptanthrin ring system; the most potent compound had a 50% effective concentration of 0.40 microM.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11850279 PMCID: PMC127471 DOI: 10.1128/AAC.46.3.882-883.2002
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191